
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current MX1 market cap is 35.83M. The company's latest EPS is AUD -0.0174 and P/E is -3.45.
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 7.55M | 6.78M | 13.09M | 22.33M | 21.93M |
Operating Income | -9.22M | -14.06M | -16.81M | -10.55M | -9.55M |
Net Income | -10.07M | -14.73M | -17.09M | -10.75M | -9.77M |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 33.7M | 44.68M | 31.28M | 30.3M | 26.9M |
Total Liabilities | 18.8M | 10.47M | 11.99M | 13.11M | 12.63M |
Total Equity | 14.9M | 34.21M | 19.29M | 17.19M | 14.26M |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -9.46M | -9.86M | -18.11M | -10.99M | -6.44M |
Investing | -2.2M | -901k | -1.11M | -779k | -369k |
Financing | 28.37M | 22.58M | -612k | 6.69M | 4.81M |
Market Cap | 35.83M |
Price to Earnings Ratio | -3.45 |
Price to Sales Ratio | 1.53 |
Price to Cash Ratio | 10.34 |
Price to Book Ratio | 2.36 |
Dividend Yield | - |
Shares Outstanding | 559.87M |
Average Volume (1 week) | 492.97k |
Average Volume (1 Month) | 645.64k |
52 Week Change | -41.82% |
52 Week High | 0.14 |
52 Week Low | 0.05 |
Spread (Intraday) | 0 (5.88%) |
Company Name | Micro X Limited |
Address |
a14 adelaide, south australia 5042 |
Website | https://www.micro-x.com |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions